Avantax Advisory Services Inc. Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP)
Avantax Advisory Services Inc. acquired a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 6,836 shares of the company’s stock, valued at approximately $269,000. A number of other institutional investors have also modified their […]
Avantax Advisory Services Inc. acquired a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 6,836 shares of the company’s stock, valued at approximately $269,000. A number of other institutional investors have also modified their […]
